Literature DB >> 5635756

Inactivated African horse sickness virus cell culture vaccine.

H Mirchamsy, H Taslimi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1968        PMID： 5635756      PMCID： PMC1409248     

Source DB:  PubMed          Journal:  Immunology        ISSN： 0019-2805            Impact factor:   7.397


× No keyword cloud information.
  3 in total

1.  EXTRACTION OF CELL-ASSOCIATED VIRUS WITHOUT DAMAGE OF THE CULTURE. (BRIEF REPORT).

Authors:  C HALLAUER; G KRONAUER
Journal:  Arch Gesamte Virusforsch       Date:  1965

2.  Antigenicity of beta-propiolactone-inactivated virus vaccines.

Authors:  G A LOGRIPPO; F W HARTMAN
Journal:  J Immunol       Date:  1955-08       Impact factor: 5.422

3.  African horse-sickness killed-virus tissue culture vaccine.

Authors:  Y Ozawa; S Bahrami
Journal:  Can J Comp Med Vet Sci       Date:  1966-11
  3 in total
  5 in total

1.  Inactivation of African horse-sickness virus by betapropiolactone and by pH.

Authors:  J Parker
Journal:  Arch Virol       Date:  1975       Impact factor: 2.574

2.  Immune response of horses to inactivated African horse sickness vaccines.

Authors:  Marina Rodríguez; Sunitha Joseph; Martin Pfeffer; Rekha Raghavan; Ulrich Wernery
Journal:  BMC Vet Res       Date:  2020-09-01       Impact factor: 2.741

Review 3.  African Horse Sickness: A Review of Current Understanding and Vaccine Development.

Authors:  Susan J Dennis; Ann E Meyers; Inga I Hitzeroth; Edward P Rybicki
Journal:  Viruses       Date:  2019-09-11       Impact factor: 5.048

4.  Re-parameterization of a mathematical model of African horse sickness virus using data from a systematic literature search.

Authors:  Emma L Fairbanks; Marnie L Brennan; Peter P C Mertens; Michael J Tildesley; Janet M Daly
Journal:  Transbound Emerg Dis       Date:  2022-01-12       Impact factor: 4.521

5.  Vaccination of horses with a recombinant modified vaccinia Ankara virus (MVA) expressing African horse sickness (AHS) virus major capsid protein VP2 provides complete clinical protection against challenge.

Authors:  Berta Alberca; Katarzyna Bachanek-Bankowska; Marta Cabana; Eva Calvo-Pinilla; Elisenda Viaplana; Lorraine Frost; Simon Gubbins; Alicia Urniza; Peter Mertens; Javier Castillo-Olivares
Journal:  Vaccine       Date:  2014-05-14       Impact factor: 3.641
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.